Techno-Derm, LLC has just announced an exclusive agreement to distribute NH LIMITED’s NARL line of ultrasound lipolysis beauty products in the Americas. NARL products are a breakthrough solution for fat-related disorders.
FOR IMMEDIATE RELEASE / PRURGENT
Miami, FL (August 13, 2009) - Techno-Derm, LLC has just announced an exclusive agreement to market and distribute NH LIMITED’s NARL line of ultrasound lipolysis beauty products in the Americas. NARL products offer a breakthrough solution for professional spas and medi-spas to prevent and treat fat-related disorders, bringing long-lasting solutions for slimming, health, wellness and beauty to millions.
NARL’s patented, non-invasive beauty products are designed to reduce fat (subcutaneous and visceral fat) and diminish cellulite. NARL is an abbreviation for ‘noradrenaline release.’ It’s thus named because NARL medical devices use a very safe level of ultrasound frequency and intensity (517 KHz – 110 mW/cm2) to naturally activate the release of noradrenaline (a type of nerve or stress hormone called a ‘catecholamine’ that acts like a neurotransmitter by signaling the release of glucose energy stores). When released from nerves, noradrenaline triggers natural fat cell lipolysis, or fat breakdown. As the resulting fatty acids and glycerol are released into the body, they’re burned off as energy. And since NARL’s localized stimulation is uniquely able to bypass the central nervous system, fat is more likely to stay off - permanently.
This addition to Techno-Derm’s professional product portfolio complements the existing line of non-invasive fat, lipolysis and cellulite products. Although in Techno-Derm’s official launch of NARL products is pending FDA clearance in the US, NARL products are aggressively being marketed to South and Central America.
Says Techno-Derm CEO Michel Van Welden, “There is a great need in countries like Brazil, Mexico and Venezuela for affordable fat and cellulite reduction technologies like NARL. As the first lipolysis ultrasound product of its kind, NARL has the potential to completely revolutionize the spa and medi-spa market in South America.” And of the pending FDA clearance, Van Welden says, “NARL treatments and technologies are supported by more than 7 years of clinical studies proving their safety and efficacy. No side effects have been reported. We expect to receive FDA clearance very soon.”
Techno-Derm will market and distribute NARL in the Americas (Antigua, Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Canada, Chile, Columbia, Costa Rica, Cuba,Dominica, Dominican Republic, Ecuador, El Salador, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts, Nevis, Saint Lucia, Saint Vincent, Grenadines, Suriname, Trinidad, Tobago, United States, Uruguay and Venezuela) by Techno-Derm, LLC, 1071 NE 79th Street, Ste. 101 in Miami, Florida. Techno-Derm is an independently owned and operated distributorship of industry-leading beauty, health, wellness and sport technologies and supplies. For more on NARL medical devices, please email narltechno-derm.com. For media inquiries, please contact Rebecca Hausen of ReVcom Group at 305-335-8696 or by email revcom.groupgmail.com.